Prescriptions for the insulin glargine biosimilar Semglee increased after it was granted interchangeable status with its ...

NPH insulin has a less steady effect than newer types of long-acting insulin, and may carry more risk of low blood sugar. It can still be an effective component of diabetes care, and is generally ...

Fin and Sioned have been fan favourites in this year's Race Across the World, however they have an added complication that ...

Summary: Insulin detemir is a long-acting, neutral, and soluble insulin analogue with a lower within-subject variability of fasting plasma glucose levels than isophane insulin human (NPH insulin ...

The Diabetes Injection Pens Market is expected to witness a growth rate of ~7% by 2028. The key factors driving the market ...

Brazil's Minister of Health, Alexandre Padilha and his delegation visited Gan & Lee Pharmaceuticals' headquarters on May 12, ...

Today, managed care pharmacy – which aims to ensure patients can access the drugs they need, but that the cost for employers ...

By contrast, insulin glargine — a third-generation, long-acting insulin — offers more stable 24-hour glycemic control through a single daily injection, better mimicking the body’s natural ...

Sioned and Fin, have challenged themselves and their relationship with the biggest test of all and spoke to us about ...

NVO stock gains after reporting first-quarter 2025 results, mainly due to expectations of U.S. sales recovery of its popular ...